Structure and reactivity of LpxD, the N-acyltransferase of lipid A biosynthesis.

PubWeight™: 1.34‹?› | Rank: Top 10%

🔗 View Article (PMC 1810333)

Published in Proc Natl Acad Sci U S A on March 05, 2007

Authors

Lori Buetow1, Terry K Smith, Alice Dawson, Stewart Fyffe, William N Hunter

Author Affiliations

1: Division of Biological Chemistry and Molecular Microbiology, School of Life Sciences, University of Dundee, Dundee DD1 5EH, United Kingdom.

Articles citing this

LPS remodeling is an evolved survival strategy for bacteria. Proc Natl Acad Sci U S A (2012) 2.05

Discovery of new biosynthetic pathways: the lipid A story. J Lipid Res (2008) 1.58

Crystal structure and acyl chain selectivity of Escherichia coli LpxD, the N-acyltransferase of lipid A biosynthesis. Biochemistry (2009) 1.28

Structural basis for the acyl chain selectivity and mechanism of UDP-N-acetylglucosamine acyltransferase. Proc Natl Acad Sci U S A (2007) 1.26

Steady-state kinetics and mechanism of LpxD, the N-acyltransferase of lipid A biosynthesis. Biochemistry (2008) 1.17

Crystal structure and catalytic mechanism of PglD from Campylobacter jejuni. J Biol Chem (2008) 1.10

Global transcriptomic response of Leptospira interrogans serovar Copenhageni upon exposure to serum. BMC Microbiol (2010) 1.08

Chasing acyl carrier protein through a catalytic cycle of lipid A production. Nature (2013) 1.05

Acyltransferases in bacteria. Microbiol Mol Biol Rev (2013) 0.96

Acyl chain specificity of the acyltransferases LpxA and LpxD and substrate availability contribute to lipid A fatty acid heterogeneity in Porphyromonas gingivalis. J Bacteriol (2008) 0.95

A structure-based approach to ligand discovery for 2C-methyl-D-erythritol-2,4-cyclodiphosphate synthase: a target for antimicrobial therapy. J Med Chem (2009) 0.90

The structure of LpxD from Pseudomonas aeruginosa at 1.3 Å resolution. Acta Crystallogr Sect F Struct Biol Cryst Commun (2011) 0.84

A continuous fluorescent enzyme assay for early steps of lipid A biosynthesis. Anal Biochem (2012) 0.84

Dual targeting antibacterial peptide inhibitor of early lipid A biosynthesis. ACS Chem Biol (2012) 0.83

Identification of three genes encoding for the late acyltransferases of lipid A in Cronobacter sakazakii. Mar Drugs (2013) 0.80

Structural basis for the recognition of peptide RJPXD33 by acyltransferases in lipid A biosynthesis. J Biol Chem (2014) 0.80

Structure determination of LpxD from the lipopolysaccharide-synthesis pathway of Acinetobacter baumannii. Acta Crystallogr Sect F Struct Biol Cryst Commun (2012) 0.78

Investigation of Yersinia pestis Laboratory Adaptation through a Combined Genomics and Proteomics Approach. PLoS One (2015) 0.78

Mutagenesis and Functional Analysis of the Bacterial Arginine Glycosyltransferase Effector NleB1 from Enteropathogenic Escherichia coli. Infect Immun (2016) 0.78

Kdo2 -lipid A: structural diversity and impact on immunopharmacology. Biol Rev Camb Philos Soc (2014) 0.78

The C-terminus of Bienertia sinuspersici Toc159 contains essential elements for its targeting and anchorage to the chloroplast outer membrane. Front Plant Sci (2014) 0.77

Crystal structures of acyl carrier protein in complex with two catalytic partners show a dynamic role in cellular metabolism. Chembiochem (2014) 0.75

Structures of Bacteroides fragilis uridine 5'-diphosphate-N-acetylglucosamine (UDP-GlcNAc) acyltransferase (BfLpxA). Acta Crystallogr D Biol Crystallogr (2015) 0.75

Drug Target Identification and Elucidation of Natural Inhibitors for Bordetella petrii: An In Silico Study. Genomics Inform (2016) 0.75

Structure, inhibition, and regulation of essential lipid A enzymes. Biochim Biophys Acta (2016) 0.75

Articles cited by this

Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr (2004) 227.01

The CCP4 suite: programs for protein crystallography. Acta Crystallogr D Biol Crystallogr (1994) 187.88

Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr (1997) 137.43

Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A (1991) 119.63

Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers (1983) 99.69

Automated MAD and MIR structure solution. Acta Crystallogr D Biol Crystallogr (1999) 41.65

PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr (2004) 23.86

Maximum-likelihood density modification. Acta Crystallogr D Biol Crystallogr (2000) 20.67

Lipopolysaccharide endotoxins. Annu Rev Biochem (2001) 18.88

Principles of protein-protein interactions. Proc Natl Acad Sci U S A (1996) 14.51

Dali: a network tool for protein structure comparison. Trends Biochem Sci (1995) 14.13

The immunopathogenesis of sepsis. Nature (2002) 11.83

PROMOTIF--a program to identify and analyze structural motifs in proteins. Protein Sci (1996) 6.76

Remarks about protein structure precision. Acta Crystallogr D Biol Crystallogr (1999) 5.22

A left-handed parallel beta helix in the structure of UDP-N-acetylglucosamine acyltransferase. Science (1995) 3.97

Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur J Biochem (1985) 3.76

Antibacterial agents that inhibit lipid A biosynthesis. Science (1996) 3.38

The active site of Escherichia coli UDP-N-acetylglucosamine acyltransferase. Chemical modification and site-directed mutagenesis. J Biol Chem (1999) 2.17

Biosynthesis of lipid A precursors in Escherichia coli. A cytoplasmic acyltransferase that converts UDP-N-acetylglucosamine to UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine. J Biol Chem (1987) 2.14

Crystal structures of substrate binding to Bacillus subtilis holo-(acyl carrier protein) synthase reveal a novel trimeric arrangement of molecules resulting in three active sites. Structure (2000) 1.84

Structure of the LpxC deacetylase with a bound substrate-analog inhibitor. Nat Struct Biol (2003) 1.57

Identification and analysis of the acyl carrier protein (ACP) docking site on beta-ketoacyl-ACP synthase III. J Biol Chem (2000) 1.54

Eight bacterial proteins, including UDP-N-acetylglucosamine acyltransferase (LpxA) and three other transferases of Escherichia coli, consist of a six-residue periodicity theme. FEMS Microbiol Lett (1992) 1.53

Crystal structure of LpxC, a zinc-dependent deacetylase essential for endotoxin biosynthesis. Proc Natl Acad Sci U S A (2003) 1.52

The firA gene of Escherichia coli encodes UDP-3-O-(R-3-hydroxymyristoyl)-glucosamine N-acyltransferase. The third step of endotoxin biosynthesis. J Biol Chem (1993) 1.47

Key residues responsible for acyl carrier protein and beta-ketoacyl-acyl carrier protein reductase (FabG) interaction. J Biol Chem (2003) 1.36

Molecular mechanisms involved in the pathogenesis of septic shock. Arch Med Res (2005) 1.32

Hydrocarbon rulers in UDP-N-acetylglucosamine acyltransferases. J Biol Chem (1998) 1.29

Fatty acid interactions with proteins: what X-ray crystal and NMR solution structures tell us. Prog Lipid Res (2004) 1.17

The novel hexapeptide motif found in the acyltransferases LpxA and LpxD of lipid A biosynthesis is conserved in various bacteria. FEBS Lett (1994) 1.17

Structure of UDP-N-acetylglucosamine acyltransferase with a bound antibacterial pentadecapeptide. Proc Natl Acad Sci U S A (2006) 1.15

Recombinant human PPAR-beta/delta ligand-binding domain is locked in an activated conformation by endogenous fatty acids. J Mol Biol (2006) 1.14

Mutants carrying conditionally lethal mutations in outer membrane genes omsA and firA (ssc) are phenotypically similar, and omsA is allelic to firA. J Bacteriol (1992) 1.08

Identification and sequence analysis of the gene mutated in the conditionally lethal outer membrane permeability mutant SS-C of Salmonella typhimurium. EMBO J (1991) 1.04

Structural analysis of the lipopolysaccharide from Chlamydia trachomatis serotype L2. J Biol Chem (1999) 1.04

Crystal structure of UDP-N-acetylglucosamine acyltransferase from Helicobacter pylori. Proteins (2003) 1.02

Effect of Ssc protein mutations on the outer membrane permeability barrier function in Salmonella typhimurium: a study using ssc mutant alleles made by site-directed mutagenesis. FEMS Microbiol Lett (1992) 0.83

Crystallization and preliminary X-ray crystallographic analysis of UDP-N-acetylglucosamine acyltransferase from Helicobacter pylori. Acta Crystallogr D Biol Crystallogr (2002) 0.78

Articles by these authors

ELM server: A new resource for investigating short functional sites in modular eukaryotic proteins. Nucleic Acids Res (2003) 6.86

The Kennedy pathway--De novo synthesis of phosphatidylethanolamine and phosphatidylcholine. IUBMB Life (2010) 2.03

TarO: a target optimisation system for structural biology. Nucleic Acids Res (2008) 1.89

Genome-wide expression profiling of in vivo-derived bloodstream parasite stages and dynamic analysis of mRNA alterations during synchronous differentiation in Trypanosoma brucei. BMC Genomics (2009) 1.67

ALDH2 mediates 5-nitrofuran activity in multiple species. Chem Biol (2012) 1.48

Leishmania TDR1 structure, a unique trimeric glutathione transferase capable of deglutathionylation and antimonial prodrug activation. Proc Natl Acad Sci U S A (2012) 1.45

Cloning of Trypanosoma brucei and Leishmania major genes encoding the GlcNAc-phosphatidylinositol de-N-acetylase of glycosylphosphatidylinositol biosynthesis that is essential to the African sleeping sickness parasite. J Biol Chem (2002) 1.28

Leishmania trypanothione synthetase-amidase structure reveals a basis for regulation of conflicting synthetic and hydrolytic activities. J Biol Chem (2008) 1.26

New secreted toxins and immunity proteins encoded within the Type VI secretion system gene cluster of Serratia marcescens. Mol Microbiol (2012) 1.25

Characterization of the Mycobacterium tuberculosis 4-diphosphocytidyl-2-C-methyl-D-erythritol synthase: potential for drug development. J Bacteriol (2007) 1.23

Structure of 2C-methyl-D-erythritol 2,4- cyclodiphosphate synthase: an essential enzyme for isoprenoid biosynthesis and target for antimicrobial drug development. Proc Natl Acad Sci U S A (2002) 1.23

Biosynthesis of isoprenoids: crystal structure of 4-diphosphocytidyl-2C-methyl-D-erythritol kinase. Proc Natl Acad Sci U S A (2003) 1.18

The glycosylphosphatidylinositol (GPI) biosynthetic pathway of bloodstream-form Trypanosoma brucei is dependent on the de novo synthesis of inositol. Mol Microbiol (2006) 1.14

Phosphatidylinositol synthesis is essential in bloodstream form Trypanosoma brucei. Biochem J (2006) 1.14

Specificity and mechanism of Acinetobacter baumanii nicotinamidase: implications for activation of the front-line tuberculosis drug pyrazinamide. Angew Chem Int Ed Engl (2009) 1.14

Recombinant human PPAR-beta/delta ligand-binding domain is locked in an activated conformation by endogenous fatty acids. J Mol Biol (2006) 1.14

Isotopic polymorphism in pyridine. Angew Chem Int Ed Engl (2009) 1.13

Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development. Proc Natl Acad Sci U S A (2008) 1.13

Crystal structures of Trypanosoma brucei and Staphylococcus aureus mevalonate diphosphate decarboxylase inform on the determinants of specificity and reactivity. J Mol Biol (2007) 1.13

High-resolution crystal structure of Trypanosoma brucei UDP-galactose 4'-epimerase: a potential target for structure-based development of novel trypanocides. Mol Biochem Parasitol (2003) 1.13

Structure and reactivity of Trypanosoma brucei pteridine reductase: inhibition by the archetypal antifolate methotrexate. Mol Microbiol (2006) 1.11

Mechanistic implications for Escherichia coli cofactor-dependent phosphoglycerate mutase based on the high-resolution crystal structure of a vanadate complex. J Mol Biol (2002) 1.10

One scaffold, three binding modes: novel and selective pteridine reductase 1 inhibitors derived from fragment hits discovered by virtual screening. J Med Chem (2009) 1.08

Structure of Staphylococcus aureus EsxA suggests a contribution to virulence by action as a transport chaperone and/or adaptor protein. J Mol Biol (2008) 1.08

Lipidomic analysis of bloodstream and procyclic form Trypanosoma brucei. Parasitology (2010) 1.08

Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands. J Med Chem (2006) 1.06

A photoactivated trans-diammine platinum complex as cytotoxic as cisplatin. Chemistry (2006) 1.05

Mitochondrial fatty acid synthesis is required for normal mitochondrial morphology and function in Trypanosoma brucei. Mol Microbiol (2008) 1.05

Induced-fit recognition of DNA by organometallic complexes with dynamic stereogenic centers. Proc Natl Acad Sci U S A (2003) 1.04

Structure of tagatose-1,6-bisphosphate aldolase. Insight into chiral discrimination, mechanism, and specificity of class II aldolases. J Biol Chem (2002) 1.03

The N-acetyl-D-glucosaminylphosphatidylinositol De-N-acetylase of glycosylphosphatidylinositol biosynthesis is a zinc metalloenzyme. J Biol Chem (2005) 1.03

Crystal structures of penicillin-binding protein 3 from Pseudomonas aeruginosa: comparison of native and antibiotic-bound forms. J Mol Biol (2010) 1.03

Hexameric assembly of the bifunctional methylerythritol 2,4-cyclodiphosphate synthase and protein-protein associations in the deoxy-xylulose-dependent pathway of isoprenoid precursor biosynthesis. J Biol Chem (2004) 1.02

The ethanolamine branch of the Kennedy pathway is essential in the bloodstream form of Trypanosoma brucei. Mol Microbiol (2009) 1.01

Symmetrical choline-derived dications display strong anti-kinetoplastid activity. J Antimicrob Chemother (2010) 1.01

ATG5 is essential for ATG8-dependent autophagy and mitochondrial homeostasis in Leishmania major. PLoS Pathog (2012) 1.01

The structure of Mycobacteria 2C-methyl-D-erythritol-2,4-cyclodiphosphate synthase, an essential enzyme, provides a platform for drug discovery. BMC Struct Biol (2007) 1.01

Two interacting binding sites for quinacrine derivatives in the active site of trypanothione reductase: a template for drug design. J Biol Chem (2004) 1.01

Structure and reactivity of human mitochondrial 2,4-dienoyl-CoA reductase: enzyme-ligand interactions in a distinctive short-chain reductase active site. J Biol Chem (2004) 0.99

Biosynthesis of isoprenoids: a bifunctional IspDF enzyme from Campylobacter jejuni. Eur J Biochem (2004) 0.99

Heterogeneity in ess transcriptional organization and variable contribution of the Ess/Type VII protein secretion system to virulence across closely related Staphylocccus aureus strains. Mol Microbiol (2014) 0.98

Tryparedoxins from Crithidia fasciculata and Trypanosoma brucei: photoreduction of the redox disulfide using synchrotron radiation and evidence for a conformational switch implicated in function. J Biol Chem (2003) 0.98

Structures of Leishmania major pteridine reductase complexes reveal the active site features important for ligand binding and to guide inhibitor design. J Mol Biol (2005) 0.97

Structure and reactivity of hydroxypropylphosphonic acid epoxidase in fosfomycin biosynthesis by a cation- and flavin-dependent mechanism. Proc Natl Acad Sci U S A (2005) 0.97

The AEROPATH project targeting Pseudomonas aeruginosa: crystallographic studies for assessment of potential targets in early-stage drug discovery. Acta Crystallogr Sect F Struct Biol Cryst Commun (2012) 0.97

Nucleotide substrate recognition by UDP-N-acetylglucosamine acyltransferase (LpxA) in the first step of lipid A biosynthesis. J Mol Biol (2007) 0.96

The nucleotide-binding site of Aquifex aeolicus LpxC. Acta Crystallogr Sect F Struct Biol Cryst Commun (2006) 0.96

Establishment of a structure-activity relationship of 1H-imidazo[4,5-c]quinoline-based kinase inhibitor NVP-BEZ235 as a lead for African sleeping sickness. J Med Chem (2014) 0.95

Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases. J Med Chem (2010) 0.95

Reevaluation of the PPAR-beta/delta ligand binding domain model reveals why it exhibits the activated form. Mol Cell (2006) 0.94

Pressure-induced polymorphism in phenol. Acta Crystallogr B (2002) 0.94

Phospholipases A₁. Int J Mol Sci (2011) 0.93

Characterization of Aquifex aeolicus 4-diphosphocytidyl-2C-methyl-d-erythritol kinase - ligand recognition in a template for antimicrobial drug discovery. FEBS J (2008) 0.93

Insight into the role of Escherichia coli MobB in molybdenum cofactor biosynthesis based on the high resolution crystal structure. J Biol Chem (2003) 0.92

Inhibitors of glycosyl-phosphatidylinositol anchor biosynthesis. Biochimie (2003) 0.92

Apicoplast lipoic acid protein ligase B is not essential for Plasmodium falciparum. PLoS Pathog (2007) 0.92

The structure of Serratia marcescens Lip, a membrane-bound component of the type VI secretion system. Acta Crystallogr D Biol Crystallogr (2011) 0.91

GDP-mannose pyrophosphorylase is essential in the bloodstream form of Trypanosoma brucei. Biochem J (2010) 0.91

Functional analysis of Leishmania cyclopropane fatty acid synthetase. PLoS One (2012) 0.91

The identification of isoprenoids that bind in the intersubunit cavity of Escherichia coli 2C-methyl-D-erythritol-2,4-cyclodiphosphate synthase by complementary biophysical methods. Acta Crystallogr D Biol Crystallogr (2004) 0.90

A structure-based approach to ligand discovery for 2C-methyl-D-erythritol-2,4-cyclodiphosphate synthase: a target for antimicrobial therapy. J Med Chem (2009) 0.90

Regulation of Trypanosoma brucei Total and Polysomal mRNA during Development within Its Mammalian Host. PLoS One (2013) 0.90

Models of the cytochromes: crystal structures and EPR spectral characterization of low-spin bis-imidazole complexes of (OETPP)Fe(III) having intermediate ligand plane dihedral angles. Inorg Chem (2006) 0.90

Photoelectron spectroscopy and electronic structure calculations of d1 vanadocene compounds with chelated dithiolate ligands: implications for pyranopterin Mo/W enzymes. Inorg Chem (2007) 0.89

Specificity and reactivity in menaquinone biosynthesis: the structure of Escherichia coli MenD (2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexadiene-1-carboxylate synthase). J Mol Biol (2008) 0.88

Further probing of the substrate specificities and inhibition of enzymes involved at an early stage of glycosylphosphatidylinositol (GPI) biosynthesis. Carbohydr Res (2002) 0.88

Diversity oriented syntheses of fused pyrimidines designed as potential antifolates. Org Biomol Chem (2009) 0.88

Structures of Staphylococcus aureus D-tagatose-6-phosphate kinase implicate domain motions in specificity and mechanism. J Biol Chem (2007) 0.88

Structure, substrate recognition and reactivity of Leishmania major mevalonate kinase. BMC Struct Biol (2007) 0.88

Biochemical characterization of the initial steps of the Kennedy pathway in Trypanosoma brucei: the ethanolamine and choline kinases. Biochem J (2008) 0.88

Synthesis, structure and reactivity of 5-pyranosyl-1,3,4-oxathiazol-2-ones. Carbohydr Res (2005) 0.88

Barriers to racemization in C3-symmetric complexes containing the hydrotris(2-mercapto-1-ethylimidazolyl)borate (Tm(Et)) ligand. Inorg Chem (2005) 0.87

De novo phasing of two crystal forms of tryparedoxin II using the anomalous scattering from S atoms: a combination of small signal and medium resolution reveals this to be a general tool for solving protein crystal structures. Acta Crystallogr D Biol Crystallogr (2001) 0.87

Characterization of Staphylococcus aureus EssB, an integral membrane component of the Type VII secretion system: atomic resolution crystal structure of the cytoplasmic segment. Biochem J (2013) 0.87

A class of 5-nitro-2-furancarboxylamides with potent trypanocidal activity against Trypanosoma brucei in vitro. J Med Chem (2013) 0.87

Assessment of Pseudomonas aeruginosa N5,N10-methylenetetrahydrofolate dehydrogenase-cyclohydrolase as a potential antibacterial drug target. PLoS One (2012) 0.87

Inhibition of Leishmania major pteridine reductase by 2,4,6-triaminoquinazoline: structure of the NADPH ternary complex. Acta Crystallogr D Biol Crystallogr (2004) 0.87

The crystal structure of Leishmania major 3-mercaptopyruvate sulfurtransferase. A three-domain architecture with a serine protease-like triad at the active site. J Biol Chem (2003) 0.86

Crystal structure of activated ModE reveals conformational changes involving both oxyanion and DNA-binding domains. J Mol Biol (2003) 0.86

Structural basis for type VI secreted peptidoglycan DL-endopeptidase function, specificity and neutralization in Serratia marcescens. Acta Crystallogr D Biol Crystallogr (2013) 0.86

The crystal structure of a plant 3-ketoacyl-CoA thiolase reveals the potential for redox control of peroxisomal fatty acid beta-oxidation. J Mol Biol (2006) 0.85

The essential neutral sphingomyelinase is involved in the trafficking of the variant surface glycoprotein in the bloodstream form of Trypanosoma brucei. Mol Microbiol (2010) 0.85

Structure of Staphylococcus aureus1,4-dihydroxy-2-naphthoyl-CoA synthase (MenB) in complex with acetoacetyl-CoA. Acta Crystallogr Sect F Struct Biol Cryst Commun (2007) 0.85

Depletion of mitochondrial acyl carrier protein in bloodstream-form Trypanosoma brucei causes a kinetoplast segregation defect. Eukaryot Cell (2011) 0.85

Pressure-induced formation of a solvate of paracetamol. Chem Commun (Camb) (2003) 0.84

Fluorescent inhibitors for IspF, an enzyme in the non-mevalonate pathway for isoprenoid biosynthesis and a potential target for antimalarial therapy. Angew Chem Int Ed Engl (2006) 0.84

Structure of Pseudomonas aeruginosa inosine 5'-monophosphate dehydrogenase. Acta Crystallogr Sect F Struct Biol Cryst Commun (2013) 0.84

A double mutation of Escherichia coli2C-methyl-D-erythritol-2,4-cyclodiphosphate synthase disrupts six hydrogen bonds with, yet fails to prevent binding of, an isoprenoid diphosphate. Acta Crystallogr Sect F Struct Biol Cryst Commun (2005) 0.84

The crystal structure of Leishmania major N(5),N(10)-methylenetetrahydrofolate dehydrogenase/cyclohydrolase and assessment of a potential drug target. Mol Biochem Parasitol (2011) 0.84